Aurinia Pharmaceuticals AUPH Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's current debt?
- Aurinia Pharmaceuticals (AUPH) reported current debt of $16.52M in Q1 2026.
- How has Aurinia Pharmaceuticals's current debt changed year-over-year?
- Aurinia Pharmaceuticals's current debt increased by 13.9% year-over-year, from $14.51M to $16.52M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.